ENT devices are used to diagnose and treat disorders related to ear, nose and throat. An Ossicular Reconstruction device is a prosthesis intended to be implanted for the functional reconstruction of markets of the middle ear ossicles (malleus, incus, and stapes) and facilitate the conduction of sound waves from the tympanic membrane to the inner ear. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ossicular reconstruction devices market, including market shares of different players within Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the ossicular reconstruction market in Japan was Grace Medical followed by Olympus, Heinz Kurz GmbH Medizintechnik and Medtronic.
Ossicular Reconstruction devices include Total Ossicular Replacement Prostheses, Partial Ossicular Replacement Prostheses, and Ossicular Reconstruction Pistons. A Total Ossicular Replacement Prosthesis (TORP) is used when the entire ossicular chain is damaged. A Partial Ossicular Replacement Prosthesis (PORP) is used when only part of the ossicular chain is damaged (i.e. , malleus and incus, but not stapes). An Ossicular Reconstruction Piston is used when the stapes becomes ossified and thus, immobile.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the ossicular reconstruction devices market within Japan was expected to be over $1m in 2021.
For the latest complete market share analysis of ossicular reconstruction device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
